Searched for
METROPOLIS DIAGNOSTICS
Scanning cancer, up close & personal: A revolution is underway in cancer diagnosisA gene-based test called next-generation sequencing can identify precise mutations, which can then be treated with targeted therapies. Sinc...- Hospital expansion cycle to keep margins rangebound, but 18 per cent revenue growth trend likely to sustain: Kotak SecuritiesIndian hospitals are set for strong revenue growth. Brokerage firm Kotak Securities predicts double-digit gains. EBITDA margins are expecte...
- Last date to buy these four stocks for dividends. Do you own any?Investors have a final chance today, May 18, to purchase shares of Alicon Castalloy, Atishay, Man InfraConstruction, and Metropolis Healthc...
- Dividends, stock splits: L&T, Havells among 15 stocks turning ex-date this week. Check detailsInvestors should note upcoming corporate actions. Several companies including GM Breweries, Havells India, and Larsen & Toubro will turn ex...
- Open to 4-5 acquisitions, but at sensible valuations: Ameera Shah, promoter and executive chairperson, Metropolis HealthcareMetropolis Healthcare is set for its next growth phase. The diagnostic chain will focus on genomics and specialty diagnostics. Strategic ac...
- Metropolis Healthcare sees strong Q4 performance driven by specialty and preventive testing pushMetropolis Healthcare reported a strong Q4 with significant growth in revenue, patient volumes, and profitability, driven by a shift toward...
- Earnings are strong, but margin pain is coming; Dharmesh Kant on 3 sectors worth owning nowIndian corporate profits are currently strong. However, rising input costs present a significant challenge ahead. Investors should remain p...
- Metropolis Healthcare to acquire Core Diagnostics for Rs 247 crMetropolis will acquire a 100% stake in Core Diagnostics financing Rs 135.76 crores or 55% in cash and the rest Rs 111.07 through an equity...
- Diagnostics chains at inflexion point: Emkay"With competitive intensity reducing after the emergence of the new normal post-pandemic, we believe Indian organised diagnostics chains st...
- Metropolis is gearing up to serve a larger segment of consumers: Ameera Shah, MDIt plans to achieve this by adding 90 more labs and 1,800 collection centres in tier-2 and tier-3 locations in the next 2-3 years, and inve...
- GSK Velu in talks with investors, PEs & banking firms to buy Metropolis Healthcare stakeMetropolis chief executive Ameera Shah and her family has initiated a formal process to sell part of the promoter stake and is understood t...
- Amazon, Walmart's Flipkart in talks to buy stake in $1.1 billion diagnostics chain Metropolis HealthcareThe company is in early discussions with several global strategic investors and other potential purchasers of the shares, said the people, ...
- Diagnostic industry has to first learn to tackle some challenges before trying to growThe diagnostic healthcare industry was among the few industries in the economy that had strong tailwinds during the pandemic.
- Metropolis Healthcare up 0.7% as board approves acquisition of Hitech DiagnosticMetropolis Healthcare said the deal would be worth Rs 636 crore.
- Diagnostic chains eye IPO route to raise fundsThe euphoria is aided by a massive spike in the share prices of already listed entities such as Metropolis Healthcare, Dr Lal Pathlabs, Med...
- Metropolis Healthcare to acquire Hitech Diagnostic Centre in a cash, stock dealS P Ganesan, its promoter and founder, will be part of the leadership team for the next few years to enable a smooth transition and integra...
- Metropolis: Tests OK, wait for listing to get clearer prognosisIn a highly fragmented, competitive, regional market, Metropolis is an organised national player.
- Metropolis eyes SRL in spinoff dealMetropolis was exploring a consolidation deal which could make it the largest diagnostics chain in Asia’s third-largest economy, sources sa...
- Metropolis, SRL scout for buys in South AfricaCompanies in talks with pathology chains.
- SRL in talks to acquire Piramal DiagnosticsDiagnostic chain Super Religare Laboratories is in advanced talks to buy Piramal Healthcare’s diagnostic chain for up to Rs 800 crore.
Load More
